Prescription drug · NDA
Elliotts B NDC 55792-007
Sodium chloride 73 mg/10mL + 6 more ingredients · Injection · Intrathecal · Lukare Medical, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55792-007-10 | 55792000710 | 10 AMPULE in 1 BOX (55792-007-10) / 10 mL in 1 AMPULE (55792-007-01)Marketed from Jun 4, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Elliotts B
- Generic name (nonproprietary)
- sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
- Active ingredients
- Sodium chloride — 73 mg/10mLSodium bicarbonate — 19 mg/10mLAnhydrous dextrose — 8 mg/10mLMagnesium sulfate, Unspecified form — 3 mg/10mLPotassium chloride — 3 mg/10mLCalcium chloride — 2 mg/10mLSodium phosphate — 2 mg/10mL
- Dosage form
- Injection
- Route
- Intrathecal
- Labeler
- Lukare Medical, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020577
- Marketing start
- Listing expires
- Other FDA classes
- Alkalinizing Activity (Mechanism)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 55792-007_4a638cd1-6922-477a-aa17-a70865ae0bd8SPL ID 4a638cd1-6922-477a-aa17-a70865ae0bd8SPL set ID 08036dbd-55b3-47b9-9890-000f253544f3UNII 451W47IQ8X, 8MDF5V39QO, 5SL0G7R0OK, DE08037SAB, 660YQ98I10, M4I0D6VV5M, SE337SVY37UPC 0355792007103
- Pharmacologic class
- Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N455792000710followed by a unit qualifier and the quantityPackage 55792-0007-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.
Excerpt only. Read the full label for complete information.